Dialyzer Reuse and Outcomes of High Flux Dialysis.
The bulk of randomized trial evidence for the expanding use of High Flux (HF) hemodialysis worldwide comes from two randomized controlled trials, one of which (HEMODIALYSIS, HEMO) allowed, while the other (Membrane Outcomes Permeability, MPO) excluded, the reuse of membranes. It is not known whether...
Main Authors: | Christos Argyropoulos, Maria-Eleni Roumelioti, Abdus Sattar, John A Kellum, Lisa Weissfeld, Mark L Unruh |
---|---|
Format: | Article |
Language: | English |
Published: |
Public Library of Science (PLoS)
2015-01-01
|
Series: | PLoS ONE |
Online Access: | http://europepmc.org/articles/PMC4461247?pdf=render |
Similar Items
-
All-cause and cause-specific mortality associated with diabetes in prevalent hemodialysis patients
by: Sattar Abdus, et al.
Published: (2012-10-01) -
Dialyzer reuse: is it safe and worth it?
by: Ashish Upadhyay -
Dialyzer Reuse Impact on Dialyzer Efficiency, Patient Morbidity and Mortality and Cost Effectiveness
by: Mitwalli Ahmed, et al.
Published: (2001-01-01) -
Serum osteoprotegerin level in hemodialysis patients using low-flux reused dialyzer in relation to atherosclerosis
by: Bui Thi Thu, H., et al.
Published: (2021) -
Clinical and microbiological effects of dialyzers reuse in hemodialysis patients
by: Isabella Carvalho Ribeiro, et al.
Published: (2019-01-01)